bg
R

Relmada Therapeutics (RLMD)

$000.00 0.00% ($0.00)

  • اليوم
  • الأسبوع
  • الشهر
  • السنة
  • ٥ سنوات
  • حتى اليوم
barakagetbaraka.com

عن Relmada Therapeutics (RLMD)

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... اقرأ أكثر

  • USD3.33
  • USD3.94
  • USD3.32
  • USD3.71
  • 61.30%
  • --
  • 1.95M
  • 1.16M
  • 194M
  • 0.24
  • 1.20%

أخبار الأسهم